Analysis of endovascular graft treatment for aortoiliac occlusive disease

What is its role based on midterm results?

Reese A. Wain, Frank J. Veith, Michael L. Marin, Takao Ohki, William D. Suggs, Jacob Cynamon, Jamie Goldsmith, Luis A. Sanchez

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: To analyze the authors' midterm results (up to 4 years) using endovascular grafts to treat aortoiliac occlusive disease in patients with limb-threatening ischemia. Summary Background Data: Endovascular grafts are being used to manage some aortoiliac lesions formerly treated by aortofemoral or extraanatomic bypass grafts. However, widespread acceptance of these new grafts depends on their late patency and clinical utility. Methods: Between January 1993 and December 1997, 52 patients with aortoiliac occlusive disease were treated with endovascular grafts. The primary indication for treatment was gangrene or ulceration in 42 patients (81%) and rest pain in 10 patients (19%). Sixteen patients had symptomatic contralateral limbs that were also treated, and 27 (52%) patients required a synchronous infrainguinal bypass. Results up to 4 years were evaluated by life table analysis. Results: Forty- six (88%) of the patients had complete follow-up of 3 to 57 months (median 22 months). Six patients were lost to follow-up at a mean of 20 months after surgery. The 4-year primary and secondary patency rates for the endovascular grafts were 66.1% and 72.3% respectively. Six patients required a major amputation, and the limb salvage rate was 88.7%. Four-year patient survival was 37%, with 23 patients dying during this follow-up period. Conclusions: Endovascular grafts can often be used when conventional procedures are contraindicated or technically impractical. These grafts are a valuable alternative to extraanatomic and aortofemoral bypasses in high-risk patients with aortoiliac occlusive disease and critical ischemia.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalAnnals of Surgery
Volume230
Issue number2
DOIs
StatePublished - Aug 1999

Fingerprint

Transplants
Therapeutics
Ischemia
Extremities
Limb Salvage
Life Tables
Gangrene
Lost to Follow-Up
Amputation
Pain
Survival

ASJC Scopus subject areas

  • Surgery

Cite this

Analysis of endovascular graft treatment for aortoiliac occlusive disease : What is its role based on midterm results? / Wain, Reese A.; Veith, Frank J.; Marin, Michael L.; Ohki, Takao; Suggs, William D.; Cynamon, Jacob; Goldsmith, Jamie; Sanchez, Luis A.

In: Annals of Surgery, Vol. 230, No. 2, 08.1999, p. 145-151.

Research output: Contribution to journalArticle

Wain, Reese A. ; Veith, Frank J. ; Marin, Michael L. ; Ohki, Takao ; Suggs, William D. ; Cynamon, Jacob ; Goldsmith, Jamie ; Sanchez, Luis A. / Analysis of endovascular graft treatment for aortoiliac occlusive disease : What is its role based on midterm results?. In: Annals of Surgery. 1999 ; Vol. 230, No. 2. pp. 145-151.
@article{f0479ff6ccba42658275e365a988d319,
title = "Analysis of endovascular graft treatment for aortoiliac occlusive disease: What is its role based on midterm results?",
abstract = "Objective: To analyze the authors' midterm results (up to 4 years) using endovascular grafts to treat aortoiliac occlusive disease in patients with limb-threatening ischemia. Summary Background Data: Endovascular grafts are being used to manage some aortoiliac lesions formerly treated by aortofemoral or extraanatomic bypass grafts. However, widespread acceptance of these new grafts depends on their late patency and clinical utility. Methods: Between January 1993 and December 1997, 52 patients with aortoiliac occlusive disease were treated with endovascular grafts. The primary indication for treatment was gangrene or ulceration in 42 patients (81{\%}) and rest pain in 10 patients (19{\%}). Sixteen patients had symptomatic contralateral limbs that were also treated, and 27 (52{\%}) patients required a synchronous infrainguinal bypass. Results up to 4 years were evaluated by life table analysis. Results: Forty- six (88{\%}) of the patients had complete follow-up of 3 to 57 months (median 22 months). Six patients were lost to follow-up at a mean of 20 months after surgery. The 4-year primary and secondary patency rates for the endovascular grafts were 66.1{\%} and 72.3{\%} respectively. Six patients required a major amputation, and the limb salvage rate was 88.7{\%}. Four-year patient survival was 37{\%}, with 23 patients dying during this follow-up period. Conclusions: Endovascular grafts can often be used when conventional procedures are contraindicated or technically impractical. These grafts are a valuable alternative to extraanatomic and aortofemoral bypasses in high-risk patients with aortoiliac occlusive disease and critical ischemia.",
author = "Wain, {Reese A.} and Veith, {Frank J.} and Marin, {Michael L.} and Takao Ohki and Suggs, {William D.} and Jacob Cynamon and Jamie Goldsmith and Sanchez, {Luis A.}",
year = "1999",
month = "8",
doi = "10.1097/00000658-199908000-00003",
language = "English (US)",
volume = "230",
pages = "145--151",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Analysis of endovascular graft treatment for aortoiliac occlusive disease

T2 - What is its role based on midterm results?

AU - Wain, Reese A.

AU - Veith, Frank J.

AU - Marin, Michael L.

AU - Ohki, Takao

AU - Suggs, William D.

AU - Cynamon, Jacob

AU - Goldsmith, Jamie

AU - Sanchez, Luis A.

PY - 1999/8

Y1 - 1999/8

N2 - Objective: To analyze the authors' midterm results (up to 4 years) using endovascular grafts to treat aortoiliac occlusive disease in patients with limb-threatening ischemia. Summary Background Data: Endovascular grafts are being used to manage some aortoiliac lesions formerly treated by aortofemoral or extraanatomic bypass grafts. However, widespread acceptance of these new grafts depends on their late patency and clinical utility. Methods: Between January 1993 and December 1997, 52 patients with aortoiliac occlusive disease were treated with endovascular grafts. The primary indication for treatment was gangrene or ulceration in 42 patients (81%) and rest pain in 10 patients (19%). Sixteen patients had symptomatic contralateral limbs that were also treated, and 27 (52%) patients required a synchronous infrainguinal bypass. Results up to 4 years were evaluated by life table analysis. Results: Forty- six (88%) of the patients had complete follow-up of 3 to 57 months (median 22 months). Six patients were lost to follow-up at a mean of 20 months after surgery. The 4-year primary and secondary patency rates for the endovascular grafts were 66.1% and 72.3% respectively. Six patients required a major amputation, and the limb salvage rate was 88.7%. Four-year patient survival was 37%, with 23 patients dying during this follow-up period. Conclusions: Endovascular grafts can often be used when conventional procedures are contraindicated or technically impractical. These grafts are a valuable alternative to extraanatomic and aortofemoral bypasses in high-risk patients with aortoiliac occlusive disease and critical ischemia.

AB - Objective: To analyze the authors' midterm results (up to 4 years) using endovascular grafts to treat aortoiliac occlusive disease in patients with limb-threatening ischemia. Summary Background Data: Endovascular grafts are being used to manage some aortoiliac lesions formerly treated by aortofemoral or extraanatomic bypass grafts. However, widespread acceptance of these new grafts depends on their late patency and clinical utility. Methods: Between January 1993 and December 1997, 52 patients with aortoiliac occlusive disease were treated with endovascular grafts. The primary indication for treatment was gangrene or ulceration in 42 patients (81%) and rest pain in 10 patients (19%). Sixteen patients had symptomatic contralateral limbs that were also treated, and 27 (52%) patients required a synchronous infrainguinal bypass. Results up to 4 years were evaluated by life table analysis. Results: Forty- six (88%) of the patients had complete follow-up of 3 to 57 months (median 22 months). Six patients were lost to follow-up at a mean of 20 months after surgery. The 4-year primary and secondary patency rates for the endovascular grafts were 66.1% and 72.3% respectively. Six patients required a major amputation, and the limb salvage rate was 88.7%. Four-year patient survival was 37%, with 23 patients dying during this follow-up period. Conclusions: Endovascular grafts can often be used when conventional procedures are contraindicated or technically impractical. These grafts are a valuable alternative to extraanatomic and aortofemoral bypasses in high-risk patients with aortoiliac occlusive disease and critical ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0033504323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033504323&partnerID=8YFLogxK

U2 - 10.1097/00000658-199908000-00003

DO - 10.1097/00000658-199908000-00003

M3 - Article

VL - 230

SP - 145

EP - 151

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 2

ER -